A n d e r s o n ,a n dH Role of L3T4+ and Lyt-2+ cells in experimental visceral leishmaniasis, Journal of Immunology, vol.140, issue.11, pp.3971-3977, 1988. ,
Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis, Nature Immunology, vol.3, issue.12, pp.1185-1191, 2002. ,
DOI : 10.1038/ni861
B7-H1 Blockade Increases Survival of Dysfunctional CD8+ T Cells and Confers Protection against Leishmania donovani Infections, PLoS Pathogens, vol.93, issue.5, 2009. ,
DOI : 10.1371/journal.ppat.1000431.s007
Loss of Dendritic Cell Migration and Impaired Resistance to Leishmania donovani Infection in Mice Deficient in CCL19 and CCL21, The Journal of Immunology, vol.176, issue.9, pp.5486-5493, 2006. ,
DOI : 10.4049/jimmunol.176.9.5486
Ar o l ef o r tumor necrosis factor-? in remodeling the splenic marginal zone during Leishmania donovani infection, American Journal of Pathology, vol.161, issue.2, pp.429-437, 2002. ,
Balancing immunity and pathology in visceral leishmaniasis, Immunology and Cell Biology, vol.42, issue.2, pp.138-147, 2007. ,
DOI : 10.1038/sj.icb7100011
The immunopathology of experimental visceral leishmaniasis, Immunological Reviews, vol.146, issue.1, pp.239-253, 2004. ,
DOI : 10.1128/IAI.71.1.401-410.2003
Organ-specific immune responses associated with infectious disease, Immunology Today, vol.21, issue.2, pp.73-78, 2000. ,
DOI : 10.1016/S0167-5699(99)01549-2
Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection, European Journal of Immunology, vol.28, issue.02, pp.687-695, 1998. ,
DOI : 10.1002/(SICI)1521-4141(199802)28:02<687::AID-IMMU687>3.3.CO;2-E
Distinct roles for IL-6 and IL-12p40 in mediating protection againstLeishmania donovani and the expansion of IL-10+ CD4+ T cells, European Journal of Immunology, vol.169, issue.7, pp.1764-1771, 2006. ,
DOI : 10.1002/eji.200635937
Destruction of follicular dendritic cells during chronic visceral leishmaniasis, Journal of Immunology, vol.158, issue.8, pp.3813-3821, 1997. ,
Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice, Journal of Clinical Investigation, vol.120, issue.4, pp.1204-1216, 2010. ,
DOI : 10.1172/JCI41281DS1
THE B7 FAMILY REVISITED, Annual Review of Immunology, vol.23, issue.1, pp.515-548, 2005. ,
DOI : 10.1146/annurev.immunol.23.021704.115611
Co-inhibitory molecules of the B7???CD28 family in the control of T-cell immunity, Nature Reviews Immunology, vol.4, issue.5, pp.336-347, 2004. ,
DOI : 10.1038/nri1349
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation, The Journal of Experimental Medicine, vol.142, issue.7, pp.1027-1034, 2000. ,
DOI : 10.1016/0008-8749(91)90091-O
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion, Nature Medicine, vol.8, issue.8, pp.793-800, 2002. ,
CD8 Cells of Patients with Diffuse Cutaneous Leishmaniasis Display Functional Exhaustion: The Latter Is Reversed, In Vitro, by TLR2 Agonists, PLoS Neglected Tropical Diseases, vol.124, issue.5, p.871, 2010. ,
DOI : 10.1371/journal.pntd.0000871.g006
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells, The Journal of Immunology, vol.182, issue.11, pp.6659-6669, 2009. ,
DOI : 10.4049/jimmunol.0804211
Lymphocyte Activation Gene-3 (CD223) Regulates the Size of the Expanding T Cell Population Following Antigen Activation In Vivo, The Journal of Immunology, vol.172, issue.9, pp.5450-5455, 2004. ,
DOI : 10.4049/jimmunol.172.9.5450
The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells, European Journal of Immunology, vol.33, issue.4, pp.970-979, 2003. ,
DOI : 10.1002/eji.200323382
Role of costimulatory molecules in immune response of patients with cutaneous leishmaniasis, Microbes and Infection, vol.7, issue.1, pp.86-92, 2005. ,
DOI : 10.1016/j.micinf.2004.09.015
B7-2 blockade enhances T cell responses to Leishmania donovani, Journal of Immunology, vol.159, issue.9, pp.4460-4466, 1997. ,
Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing ofLeishmania donovani, European Journal of Immunology, vol.34, issue.5, pp.1433-1440, 2004. ,
DOI : 10.1002/eji.200324021
Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani, Journal of Immunology, vol.161, issue.8, pp.4153-4160, 1998. ,
Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy, Infection and Immunity, vol.70, issue.11, pp.6284-6293, 2002. ,
DOI : 10.1128/IAI.70.11.6284-6293.2002
IL-10 mediates susceptibility to Leishmania donovani infection, European Journal of Immunology, vol.31, issue.10, pp.2848-2856, 2001. ,
DOI : 10.1002/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.3.CO;2-K
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity, Nature, vol.223, issue.6915, pp.502-507, 2002. ,
DOI : 10.1038/nature01152
Interleukin-10 and the pathogenesis of human visceral leishmaniasis, Trends in Immunology, vol.28, issue.9, pp.378-384, 2007. ,
DOI : 10.1016/j.it.2007.07.004
A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome, Proceedings of the National Academy of Sciences, vol.106, issue.40, pp.17123-17128, 2009. ,
DOI : 10.1073/pnas.0904955106
Posttranscriptional Regulation of Il10 Gene Expression Allows Natural Killer Cells to Express Immunoregulatory Function, Immunity, vol.29, issue.2, pp.295-305, 2008. ,
DOI : 10.1016/j.immuni.2008.06.012
Stromal Cells Direct Local Differentiation of Regulatory Dendritic Cells, Immunity, vol.21, issue.6, pp.805-816, 2004. ,
DOI : 10.1016/j.immuni.2004.10.012
Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway, Journal of Immunology, vol.132, issue.4, pp.2072-2077, 1984. ,
Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation, European Journal of Immunology, vol.166, issue.5, pp.1355-1368, 2010. ,
DOI : 10.1002/eji.200939455
B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology, Journal of Immunology, vol.164, issue.7, pp.3681-3688, 2000. ,
Regulatory B Cells Shape the Development of Th2 Immune Responses in BALB/c Mice Infected with Leishmania major Through IL-10 Production, The Journal of Immunology, vol.184, issue.2, pp.886-894, 2010. ,
DOI : 10.4049/jimmunol.0901114
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania, Journal of Experimental Medicine, vol.201, issue.5, pp.747-754, 2005. ,
The Role of IL-10 in Promoting Disease Progression in Leishmaniasis, The Journal of Immunology, vol.166, issue.2, pp.1141-1147, 2001. ,
DOI : 10.4049/jimmunol.166.2.1141
MARGINAL-ZONE B CELLS, Nature Reviews Immunology, vol.182, issue.5, pp.323-335, 2002. ,
DOI : 10.1016/S0167-5699(98)01308-5
Development and selection of marginal zone B cells, Immunological Reviews, vol.170, issue.1, pp.192-205, 2004. ,
DOI : 10.1016/S1074-7613(01)00129-7
Blood Dendritic Cells Interact with Splenic Marginal Zone B Cells to Initiate T-Independent Immune Responses, Immunity, vol.17, issue.3, pp.341-352, 2002. ,
DOI : 10.1016/S1074-7613(02)00389-8
IgM(high)CD21(high) lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells, Journal of Immunology, vol.162, issue.12, pp.7198-7207, 1999. ,
Follicular shuttling of marginal zone B cells facilitates antigen transport, Nature Immunology, vol.106, issue.1, pp.54-62, 2008. ,
DOI : 10.1126/science.1136736
Analyses of the In Vivo Trafficking of Stoichiometric Doses of an Anti-Complement Receptor 1/2 Monoclonal Antibody Infused Intravenously in Mice, The Journal of Immunology, vol.173, issue.4, pp.2297-2306, 2004. ,
DOI : 10.4049/jimmunol.173.4.2297
Visualizing B cell capture of cognate antigen from follicular dendritic cells, Journal of Experimental Medicine, vol.206, issue.7, pp.1485-1493, 2009. ,
Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells, International Immunology, vol.16, issue.10, pp.1411-1422, 2004. ,
DOI : 10.1093/intimm/dxh142
Synergistic roles of IgM and complement in antigen trapping and follicular localization, European Journal of Immunology, vol.32, issue.8, pp.2328-2337, 2002. ,
DOI : 10.1002/1521-4141(200208)32:8<2328::AID-IMMU2328>3.0.CO;2-T
Clonal selection and learning in the antibody system, Nature, vol.381, issue.6585, pp.751-758, 1996. ,
DOI : 10.1038/381751a0
Serological investigations on Indian kala-azar, Clinical & Experimental Immunology, vol.40, issue.2, pp.318-326, 1980. ,
Nature and incidence of erythrocyte-bound IgG and some aspects of the physiopathogenesis of anaemia in American visceral leishmaniasis, Clinical & Experimental Immunology, vol.64, issue.3, pp.495-502, 1986. ,
Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis, Clinical & Experimental Immunology, vol.89, issue.3, pp.479-484, 1994. ,
DOI : 10.1111/j.1365-2249.1994.tb07022.x
Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis Leishmania majorspecific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c mice, Clinical & Experimental Immunology Journal of Immunology, vol.56, issue.180 7, pp.58-66, 1984. ,
Tissue granuloma structure-function in experimental visceral leishmaniasis, International Journal of Experimental Pathology, vol.161, issue.5, pp.249-267, 2001. ,
DOI : 10.1046/j.1365-2613.2001.00199.x
IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental Leishmaniasis, Journal of Immunology, vol.154, issue.10, pp.5320-5330, 1995. ,
Endogenous Interleukin???12 Regulates Acquired Resistance in Experimental Visceral Leishmaniasis, The Journal of Infectious Diseases, vol.175, issue.6, pp.1477-1479, 1997. ,
DOI : 10.1086/516482
Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis, Journal of Experimental Medicine, vol.181, issue.1, pp.387-391, 1995. ,
DOI : 10.1084/jem.181.1.387
M i r a l l e se ta l . , " A c q u i r e d resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity, Journal of Immunology, vol.148, issue.6, pp.1858-1863, 1992. ,
Effector role of blood monocytes in experimental visceral leishmaniasis, Infection and Immunity, vol.61, issue.4, pp.1330-1333, 1993. ,
Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection, Journal of Biological Chemistry, vol.279, issue.43, pp.45194-45207, 2004. ,
DOI : 10.1074/jbc.M400726200
Virus-specific Activation of a Novel Interferon Regulatory Factor, IRF-5, Results in the Induction of Distinct Interferon ?? Genes, Journal of Biological Chemistry, vol.276, issue.26, pp.23382-23390, 2001. ,
DOI : 10.1074/jbc.M101216200
Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response, Journal of Biological Chemistry, vol.283, issue.21, pp.14295-14308, 2008. ,
DOI : 10.1074/jbc.M800501200
Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression, Proceedings of the National Academy of Sciences, vol.104, issue.9, pp.3402-3407, 2007. ,
DOI : 10.1073/pnas.0611559104
Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors, Nature, vol.27, issue.7030, pp.243-249, 2005. ,
DOI : 10.1038/nature01850
Critical Role of IRF-5 in the Development of T helper 1 responses to Leishmania donovani infection, PLoS Pathogens, vol.165, issue.1, 2011. ,
DOI : 10.1371/journal.ppat.1001246.s003
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses, Nature Immunology, vol.161, issue.3, pp.231-238, 2011. ,
DOI : 10.1084/jem.20030026
Exploring the full spectrum of macrophage activation, Nature Reviews Immunology, vol.117, issue.12, pp.958-969, 2008. ,
DOI : 10.1038/nri2448
The phagocytes: neutrophils and monocytes, Blood, vol.112, issue.4, pp.935-945, 2008. ,
DOI : 10.1182/blood-2007-12-077917
Induction of Direct Antimicrobial Activity Through Mammalian Toll-Like Receptors, Science, vol.291, issue.5508, pp.1544-1547, 2001. ,
DOI : 10.1126/science.291.5508.1544
Nitric oxide and the immune response, Nature Immunology, vol.14, issue.11, pp.907-916, 2001. ,
DOI : 10.1038/ni1001-907
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors, Science, vol.285, issue.5428, pp.732-736, 1999. ,
DOI : 10.1126/science.285.5428.732
The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling, Journal of Biological Chemistry, vol.280, issue.17, pp.17005-17012, 2005. ,
DOI : 10.1074/jbc.M412584200
Leishmania donovani induces interferon regulatory factor in murine macrophages: a host defense response, Biochemical and Biophysical Research Communications, vol.317, issue.2, pp.639-647, 2004. ,
DOI : 10.1016/j.bbrc.2004.03.097
Innate Killing of Leishmania donovani by Macrophages of the Splenic Marginal Zone Requires IRF-7, PLoS Pathogens, vol.39, issue.8, 2010. ,
DOI : 10.1371/journal.ppat.1000813.s014
Leishmania donovani Amastigotes Impair Gamma Interferon-Induced STAT1?? Nuclear Translocation by Blocking the Interaction between STAT1?? and Importin-??5, Infection and Immunity, vol.78, issue.9, pp.3736-3743, 2010. ,
DOI : 10.1128/IAI.00046-10
URL : https://hal.archives-ouvertes.fr/pasteur-00819552